Notice from The Thoracic Surgery Foundation for Research and Education

Notice from The Thoracic Surgery Foundation for Research and Education

1132 LATERZA ET AL NEOADJUVANT THERAPY FOR ESOPHAGEAL CARCINOMA Ann Thoral: Surg 1994:571112&32 15. Lackey VL, Reagan MT, Smith RA, et al. Neoadjuv...

212KB Sizes 0 Downloads 52 Views

1132

LATERZA ET AL NEOADJUVANT THERAPY FOR ESOPHAGEAL CARCINOMA

Ann Thoral: Surg 1994:571112&32

15. Lackey VL, Reagan MT, Smith RA, et al. Neoadjuvant therapy of squamous cell carcinoma: role of resection and benefit in partial responders. Ann Thorac Surg 1989;48: 218-21. 16. Hilgenberg AD, Carey RW, Wilkins EW, Choi NC, Mathisen DJ, Grillo HC: Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988;45: 357-63. 17. Wolfe WG, Burton GV, Seigler HF, et al. Early results with combined modality therapy for carcinoma of the esophagus. Ann Surg 1987;205:563-71. 18. MacFarlane SD, Hill LD, Jolly PC, et al. Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 1988;95:41522. 19. Parker EF, Reed CE, Marks RD. Chemotherapy, radiation therapy, and resection for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1989;98:1037-44. 20. Poplin E, Fleming T, Leichman L, et al. Combined therapies for squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987;5: 622-8. 21. Peracchia A, Debesi B, Castor0 C, et al. Results of surgery after cisplatin and 5-FU combination chemotherapy for locally advanced esophageal squamous cell carcinoma. Fourth World Congress of the International Society for Diseases of the Esophagus. Chicago, Sep 1989.

22. Bains M, Kelsen DP, Beattie EJ, et al. Treatment of esophageal carcinoma by combined preoperative chemotherapy. Ann Thorac Surg 1982;34:521-8. 23. Campbell WR, Taylor SA, Pierce GE, et al. Therapeutic alternative in patients with esophageal cancer. Annual Meeting Southwestern Surgical Congress, Las Vegas, NV, 1985. 24. Leichman L, Barry BT. Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol 1991;18:64-72. 25. Stewart FM, Harkins BJ, Hahn S S . Cisplatin, 5-fluorouracil, mitomycin C and concurrent radiationtherapy with or without esophagectomy for esophageal carcinoma. Cancer 1989; 64:622-8. 26. Carey RW, Hilgenberg AD, Wilkins EW, et al. Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy component. J Clin Oncol 1986;4:697-701. 27. Steiger Z . Perioperative multimodality management of esophageal cancer: therapeutic or investigational? Ann Thorac Surg 1990;49:345-6. 28. Al-Sarraf M. The current status of combined modality treatment containing chemotherapy in patients with esophageal cancer. Int J Radiat Oncol Biol Phys 1990;19:81?-5. 29. Laterza E, de' Manzoni G, Graziani R, et al. La stadia:zione del carcinoma dell'esofago dopo trattamento neoadiuvante preoperatorio. XV Congresso Nazionale SICO, Monduzzi Edt., Padova 1991.

Notice From The Thoracic Surgery Foundation for Research and Education Applications for grants from The Thoracic Surgery Foundation for Research and Education, including the Nina Starr Braunwald Fund, are now available. Guidelines and application materials may be obtained by writing to The

Thoracic Surgery Foundation for Research and Education, 401 N Michigan Ave, Chicago, IL 60611-4267. You may also place your request by phone (3121644-6610) oir fax (312/527-6635).